
International Journal of Peptide and Protein Research p. 323 - 329 (1976)
Update date:2022-07-29
Topics:
Channabasavaiah
Sivanandaiah
Human fibrinopeptide A, a hexadecapeptide, released by the action of thrombin on fibrinogen during clotting of blood, has been synthesized by conventional methods. The synthetic peptide as well as some of the intermediates in the synthesis have been examined for anticoagulant activity. Though all of them were found to be active, the terminal carboxyl protected peptides are more potent inhibitors of clotting than the carboxyl free peptides.
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Rugao Jinling Chemical Co., Ltd.(expird)
Contact:0086-513-68005586
Address:Lianluo new village huangshi town Rugao city Jiangsu Province.
Contact:+49-4101-3053-0
Address:Waldhofstrasse 14 ,25474 Ellerbek Germany
Changzhou naidechemical Co.Ltd
Contact:+86-519-82589807
Address:NO.25,Houyang street,Jintan,Changzhou City
Doi:10.1016/S0968-0896(03)00159-7
(2003)Doi:10.1021/ja00806a031
(1973)Doi:10.1021/jo035329s
(2004)Doi:10.1039/P19730001615
(1973)Doi:10.1021/acs.orglett.0c02287
(2020)Doi:10.1002/hlca.19510340652
(1951)